Related Experiment Video
Updated: Oct 22, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Clinical analysis of left atrial appendage occlusion for stroke prevention in elderly patients with atrial
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.
Insights
Left atrial appendage occlusion (LAAO) is safe and effective for preventing stroke in elderly patients with atrial fibrillation (AF). This procedure shows comparable perioperative safety and long-term stroke risk reduction in older adults compared to younger patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Atrial fibrillation (AF) significantly increases stroke risk, particularly in elderly patients.
- Left atrial appendage occlusion (LAAO) is an alternative to anticoagulation for stroke prevention in AF.
- Limited data exists on LAAO efficacy and safety specifically in patients over 75 years old.
Purpose of the Study:
- To evaluate the efficacy and safety of LAAO in patients with AF aged over 75 years.
- To compare perioperative complications and long-term outcomes (ischemic stroke, major bleeding) between elderly ( >75 years) and younger (≤75 years) AF patients undergoing LAAO.
Main Methods:
- Retrospective analysis of 82 AF patients who underwent successful LAAO.
- Patients were divided into an elderly group (>75 years) and a younger group (≤75 years).
- Perioperative risks and follow-up events including ischemic stroke and major bleeding were analyzed.
Main Results:
- No significant differences in perioperative ischemic stroke or major bleeding between groups.
- No deaths or pericardial tamponade occurred in either group.
- During follow-up (25.9±15.9 months), the elderly group had a stroke rate of 3.6/100 person-years and a major bleeding rate of 2.5/100 person-years; the younger group had rates of 4.9/100 person-years and 0/100 person-years, respectively. The elderly group showed a more profound relative risk reduction for stroke (32.0% vs. 25.0%).
Conclusions:
- LAAO demonstrates comparable safety and efficacy in elderly AF patients compared to younger counterparts.
- LAAO is a potentially suitable option for stroke prevention in elderly AF patients.
- While stroke risk reduction was greater in the elderly, major bleeding risk was higher, warranting careful consideration.
Abstract:
To evaluate the efficacy and safety of left atrial appendage occlusion (LAAO) in patients with atrial fibrillation (AF) over 75 years. A total of 82 patients with AF who underwent LAAO successfully in Beijing Anzhen Hospital from March 2014 to March 2019 were divided into two groups according to age: the elderly group (aged>75 years) and the young group (aged ≤75 years). Risk of perioperative complications and incidence of ischemic stroke and major bleeding during follow-up were retrospectively analyzed. The results showed that there were no significant differences in procedure-related ischemic stroke(0 vs.1.6%,P=0.768) and major bleeding (0 vs.1.6%,P=0.768) during perioperative period between the two groups. No complications as death or pericardial tamponade occurred in the two group. During a (25.9±15.9) months period of followed up, ischemic stroke event rate was 3.6/100 person-years in the elderly group and 4.9/100 person-years in the young group, respectively. Major bleeding event rate was 2.5/100 person-years in the elderly group and 0/100 person-years in the young group, respectively. Compared with the expected ones, the relative risk reduction (RRR) of stroke in the elderly group was more profound than that in the young group (32.0% vs. 25.0%), while the risk of major bleeding in the young group was significantly lower than that in the elderly group (RRR 100% vs. 56.9%). Therefore, LAAO might be suitable for stroke prevention in the elderly AF patients.
More Related Videos
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome III: Diagnostic Studies

